Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Price / Earnings (ntm)

Amag Pharmaceuticals Price / Earnings (ntm) Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Price / Earnings (ntm) from 2010 to 2017. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Amag Pharmaceuticals Price / Earnings (ntm) for the quarter ending August 08, 2017 was 80.14 a 24.95% increase of 20.00 year over year
  • Amag Pharmaceuticals Price / Earnings (ntm) for the last 12 months ending August 08, 2017 was 80.14 a 24.95% increase of 20.00 year over year
  • Amag Pharmaceuticals Annual Price / Earnings (ntm) for 2017 was 80.14 a 1.17% increase of 0.93 from 2016
  • Amag Pharmaceuticals Annual Price / Earnings (ntm) for 2017 was 79.21 a -2.95% decrease of -2.34 from 2016
  • Amag Pharmaceuticals Annual Price / Earnings (ntm) for 2017 was 81.54 a 26.24% increase of 21.40 from 2016
Other Valuation Metrics:
  • Amag Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $687m a 6.12% increase of 42m year over year
  • Amag Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 0.87 a 21.08% increase of 0.18 year over year
  • Amag Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $1,093m a 1.93% increase of 21m year over year
View Chart On Koyfin

Quarterly AMAG Price / Earnings (ntm) Data

08/201780.14
08/201779.21
08/201781.54
08/201760.14
08/201762.86
08/201761.96
08/201760.69
08/201763.41
08/201767.21
08/201769.20

Annual AMAG Price / Earnings (ntm) Data

201780.14
201779.21
201781.54
201760.14
201762.86
201761.96
201760.69
201763.41
201767.21
201769.20